Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-15-073788

SVP, General Counsel, Sec. sold 1,484 shares at $8.67 ($12,860)

From the SEC's structured data for this filing

Trades in this filing

Hadas Nicole R. · SVP, General Counsel, Sec.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-10-02 Sale : show line 1 in the form −1,484 $8.67 $12,860 65,260 D
Open-market sales · 1,484 sh · avg $8.67 · $12,860
Loading xslF345X03/doc4.xml…